Author:
Kim Julius Woongki,Auffinger Brenda,Spencer Drew A.,Miska Jason,Chang Alan L.,Kane Joshua Robert,Young Jacob S.,Kanojia Deepak,Qiao Jian,Mann Jill F.,Zhang Lingjiao,Wu Meijing,Ahmed Atique U.,Aboody Karen S.,Strong Theresa V.,Hébert Charles D.,Lesniak Maciej S.
Funder
National Institute of Neurological Disorders and Stroke
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference24 articles.
1. Kane JR, Miska J, Young JS, Kanojia D, Kim JW, Lesniak MS. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro Oncol. 2015;17(Suppl 2):ii24–36. doi:
10.1093/neuonc/nou355
.
2. Kim JW, Kane JR, Young JS, Chang A, Kanojia D, Morshed R, et al. A genetically modified adenoviral vector with a phage display derived peptide incorporated into fiber fibritin chimera prolongs survival in experimental glioma. Hum Gene Ther. 2015. doi:
10.1089/hum.2015.008
.
3. Nandi S, Lesniak MS. Adenoviral virotherapy for malignant brain tumors. Expert Opin Biol Ther. 2009;9(6):737–47. doi:
10.1517/14712590902988451
.
4. Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC, Lesniak MS. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Int J Oncol. 2009;34(3):729–42.
5. Ulasov IV, Zhu ZB, Tyler MA, Han Y, Rivera AA, Khramtsov A, et al. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. Hum Gene Ther. 2007;18(7):589–602. doi:
10.1089/hum.2007.002
.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献